Contextlogic Performance
| LOGCDelisted Stock | USD 7.39 0.14 1.93% |
The firm shows a Beta (market volatility) of 0.43, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Contextlogic's returns are expected to increase less than the market. However, during the bear market, the loss of holding Contextlogic is expected to be smaller as well. At this point, Contextlogic has a negative expected return of -0.39%. Please make sure to confirm Contextlogic's sortino ratio, semi variance, rate of daily change, as well as the relationship between the value at risk and kurtosis , to decide if Contextlogic performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Contextlogic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in September 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
| Begin Period Cash Flow | 238 M |
Contextlogic |
Contextlogic Relative Risk vs. Return Landscape
If you would invest 816.00 in Contextlogic on May 27, 2025 and sell it today you would lose (77.00) from holding Contextlogic or give up 9.44% of portfolio value over 90 days. Contextlogic is currently does not generate positive expected returns and assumes 5.0601% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of otc stocks are less volatile than Contextlogic, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Contextlogic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Contextlogic's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Contextlogic, and traders can use it to determine the average amount a Contextlogic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0778
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LOGC |
Estimated Market Risk
| 5.06 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Contextlogic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Contextlogic by adding Contextlogic to a well-diversified portfolio.
Contextlogic Fundamentals Growth
Contextlogic OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Contextlogic, and Contextlogic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Contextlogic OTC Stock performance.
| Return On Equity | -0.1 | ||||
| Return On Asset | -0.0708 | ||||
| Profit Margin | (2.86) % | ||||
| Operating Margin | (4.57) % | ||||
| Current Valuation | 49.66 M | ||||
| Shares Outstanding | 26.68 M | ||||
| Price To Earning | (3.53) X | ||||
| Price To Book | 1.36 X | ||||
| Price To Sales | 27.94 X | ||||
| Revenue | 43 M | ||||
| EBITDA | (78 M) | ||||
| Cash And Equivalents | 38.85 M | ||||
| Cash Per Share | 1.18 X | ||||
| Total Debt | 5 M | ||||
| Debt To Equity | 0.54 % | ||||
| Book Value Per Share | 5.51 X | ||||
| Cash Flow From Operations | (94 M) | ||||
| Earnings Per Share | (0.76) X | ||||
| Total Asset | 156 M | ||||
| Retained Earnings | (3.33 B) | ||||
| Current Asset | 1.47 M | ||||
| Current Liabilities | 1.14 M | ||||
About Contextlogic Performance
By analyzing Contextlogic's fundamental ratios, stakeholders can gain valuable insights into Contextlogic's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Contextlogic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Contextlogic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Logicbio Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 62 people.Things to note about Contextlogic performance evaluation
Checking the ongoing alerts about Contextlogic for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Contextlogic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Contextlogic is not yet fully synchronised with the market data | |
| Contextlogic generated a negative expected return over the last 90 days | |
| Contextlogic has high historical volatility and very poor performance | |
| Contextlogic has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 43 M. Net Loss for the year was (75 M) with profit before overhead, payroll, taxes, and interest of 1000 K. | |
| Contextlogic currently holds about 38.85 M in cash with (94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.18. | |
| Roughly 64.0% of the company shares are owned by institutional investors | |
| Latest headline from insidermonkey.com: Merit Medical Systems Lagged in Q2 Due to Tariff Concerns |
- Analyzing Contextlogic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Contextlogic's stock is overvalued or undervalued compared to its peers.
- Examining Contextlogic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Contextlogic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Contextlogic's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Contextlogic's otc stock. These opinions can provide insight into Contextlogic's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in rate. Note that the Contextlogic information on this page should be used as a complementary analysis to other Contextlogic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Contextlogic OTC Stock
If you are still planning to invest in Contextlogic check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Contextlogic's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |